Rallybio
Rallybio is a Connecticut based biopharmaceutical company that researches and develops novel therapeutics for the treatment of severe and rare disorders.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Rallybio Information
Geographic Data
Address: 234 Church Street
City: New Haven
State: CT
Zip: 06510
Country: US
Financial Info
Stage:
series b
Raised Last:
$145M
Raised Total:$182M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Rallybio is a Connecticut based biopharmaceutical company that researches and develops novel therapeutics for the treatment of severe and rare disorders.
Contact Phone:
+12038593820
Contact Email:
Rallybio went public on 7/28/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/28/2021
IPO Valuation:
$406M
Ticker Symbol:
RLYB
IPO Price:
$13/share
Amount Raised:
$81M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
